Agency Information Collection Activities: Proposed Collection; Comment Request, 61690-61692 [E9-28211]
Download as PDF
<![CDATA[
61690
Federal Register / Vol. 74, No. 226 / Wednesday, November 25, 2009 / Notices
2020 will reflect assessments of major
risks to health and wellness, changing
public health priorities, and emerging
issues related to our nation’s health
preparedness and prevention.
Public Participation at Meeting:
Members of the public are invited to
listen to the online Committee meeting.
There will be no opportunity for oral
public comments during the online
Committee meeting. Written comments,
however, are welcome throughout the
development process of the national
health promotion and disease
prevention objectives for 2020. They can
be submitted through the Healthy
People Web site at: https://
www.healthypeople.gov/hp2020/
comments/ or they can be e-mailed to
HP2020@hhs.gov.
To listen to the Committee meeting,
individuals must pre-register to attend
at the Healthy People Web site located
at https://www.healthypeople.gov.
Participation in the meeting is limited.
Registrations will be accepted until
maximum WebEx capacity is reached
and must be completed by 9 a.m. EST
on December 11, 2009. A waiting list
will be maintained should registrations
exceed WebEx capacity. Individuals on
the waiting list will be contacted as
additional space for the meeting
becomes available.
Registration questions may be
directed to Hilary Scherer at
HP2020@norc.org (e-mail), (301) 634–
9374 (phone) or (301) 634–9301 (fax).
Dated: November 18, 2009.
Penelope Slade-Sawyer,
RADM, USPHS, Deputy Assistant Secretary
for Health (Disease Prevention and Health
Promotion).
[FR Doc. E9–28320 Filed 11–24–09; 8:45 am]
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
sroberts on DSKD5P82C1PROD with NOTICES
AGENCY: Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
SUMMARY: This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project:
‘‘Spreading Techniques to Radically
Reduce Antibiotic Resistant Bacteria
VerDate Nov<24>2008
17:36 Nov 24, 2009
Jkt 220001
(Methicillin Resistant Staphylococcus
aureus, or MRSA).’’ In accordance with
the Paperwork Reduction Act, 44 U.S.C.
350 1–3520, AHRQ invites the public to
comment on this proposed information
collection.
DATES: Comments on this notice must be
received by January 25, 2010.
ADDRESSES: Written comments should
be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by
e-mail at
doris.lefkowitz@AHRQ.hhs.gov.
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
e-mail at
doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project
Spreading Techniques To Radically
Reduce Antibiotic Resistant Bacteria
(Methicillin Resistant Staphylococcus
aureus, or MRSA)
Healthcare Acquired Infections (HAIs)
caused almost 100,000 deaths among
the 2.1 million people who acquired
infections while hospitalized in 2000,
and HAI rates have risen relentlessly
since then. Alarmingly, 70% of HATs
are due to bacteria that are resistant to
commonly used antibiotics, with
Methicillin Resistant Staphylococcus
aureus (MRSA) being the most rapidly
growing, and among the most virulent,
pathogens. Resistance is increasing
rapidly in all types of hospitals (Huang
2007). Despite evidence that routinely
applied, simple interventions do work,
most hospitals have failed to make
notable progress in reducing MRSA
infections. Hospitals in some European
countries and select U.S. hospitals,
however, have succeeded with
impressive results.
Sites that have already achieved
dramatic decreases in their MRSA
infection rates have done so by
implementing precautions to prevent
transmission, using system redesign
approaches. Further, many hospitals
have successfully instituted isolation
procedures for patients suspected to be
MRSA carriers. In doing so, these
hospitals have followed the broadly
disseminated guidelines for hand
hygiene and contact isolation
precautions. This study is a follow up
to a recent study implemented in 6
hospital systems in the Indianapolis
metropolitan area that used a ‘‘MRSA
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
intervention bundle’’ composed of
active surveillance screening, contact
isolation precautions, and increased
hand hygiene. Preliminary data from
that initial study suggest a 60% decrease
in MRSA rates in participating intensive
care units (ICUs) (Doebbeling, B.
Redesigning Hospital Care for Quality
and Efficiency Applications of Positive
Deviance and Lean in Reducing MRSA.
Presentation at AHRQ Annual Meeting,
Rockville, MD, Sept 2009).
This study is designed to further test
this intervention bundle in non-ICU
settings in hospitals currently using the
intervention bundle in their ICUs, as
well as in additional ICUs in newly
recruited hospital systems. This project
will utilize the same guidelines and
precautions that were applied in the
original study, and will add an
innovative feature that will use
electronic medical record systems to
improve identifying, communicating
and tracking MRSA infections among
healthcare systems. More specifically,
this study has five aims:
(1) Further test the ‘‘MRSA
intervention bundle’’ from the original
Indianapolis MRSA study, and test the
intervention in additional units in the 4
original Indianapolis hospital systems
and an additional 3 hospital systems
beyond Indianapolis;
(2) Identify and monitor healthcare
associated community onset (HACO)
MRSA cases and controls who receive
care in participating hospitals and
affiliated settings, identify strategies to
reduce HACO MRSA and demonstrate
reduction of HACO MRSA;
(3) Assess the relative effectiveness of
various antibiotics in abatement or
eradication of MRSA carriage in
hospital patients;
(4) Evaluate the effectiveness of the
tested implementation strategies and
innovations by applying information
technology to enable consistent
collection, sharing, analysis and
reporting of data;
(5) Disseminate findings and promote
outreach to target audiences and other
stakeholders.
While many secondary data are
available for this study, Aims 1 and 2
involve primary data collection. Use of
the intervention bundle requires that
opinion leaders and front line workers
be equipped with techniques used in
the reorganization of healthcare delivery
to improve health outcomes (Singhal
and Greiner, 2007; IHI, 2005). These
techniques will assist in identifying
goals, implementing the interventions to
meet local needs and measuring and
feeding back progress on key processes
and outcomes to staff and others.
E:\FR\FM\25NON1.SGM
25NON1
Federal Register / Vol. 74, No. 226 / Wednesday, November 25, 2009 / Notices
The study also incorporates an
additional informatics surveillance
system to allow participating hospitals
to more efficiently communicate, share
and track MRSA infections. This system
will save infection control and
clinicians’ time—for example, by
electronically identifying patients with
a known history of drug-resistant
infections when they first contact a new
institution.
This study is being conducted by
AHRQ through its contractor, Indiana
University and the Regenstrief Institute,
pursuant to AHRQ’s statutory authority
to conduct and support research on
healthcare and on systems for the
delivery of such care, including
activities with respect to the quality,
effectiveness, efficiency,
appropriateness and value of healthcare
services and with respect to quality
measurement and improvement. 42
U.S.C. 299a(a)(l) and (2).
Method of Collection
There will be 3 types of data
collection to support the study Aims:
• Electronic medical record data on
MRSA infections and rates will be
collected from an existing and unique
healthcare information exchange
(Indiana Network for Patient Care or
INPC) in the Indianapolis area, and the
CDC’s National Healthcare Safety
Network (Aims 1–5).
• Data on hand washing, swabbing,
and isolation rates will be collected by
observation (Aims 1, 2, and 4).
• Four surveys will be conducted: A
brief Social Network Analysis (SNA), a
Cultural Survey, a Patient Healthcare
Use survey, and an Implementation
Assessment of key informants (Aims 1,
4, and 5).
The social network analysis
questionnaire (SNA) (Wasserman et al.,
1994) will be administered to
understand with whom hospital
personnel work, how hospital networks
mature over time and how information
is shared. Additionally, cultural beliefs,
attitudes, and knowledge will be
captured by surveying staff on
intervention units of participating
hospitals using a cultural questionnaire.
To compare changes in the network and
cultural beliefs, both the SNA and the
cultural questionnaire will be
administered to staff at baseline and
again one year later. These data will be
collected from a sample of staff in the
intervention units. Project team leaders
will select relevant staff regularly
working and providing patient care or
direct patient services on the unit in a
purposive sample. These staff will
receive the paper-based questionnaires
during staff meetings and will return
them anonymously. A study ID will
serve to determine which staff has
responded and allow linkage of baseline
and follow-up surveys.
The implementation assessment will
be an interview obtained quarterly to
key informants at each organization to
assess the approaches to
implementation of the program (e.g.,
dose, intensity, leadership support,
teamwork, etc). This assessment will be
a short (10–12) item questionnaire.
Additionally, to better understand the
healthcare associated community
acquired aspect of MRSA transmission,
200 patients will be surveyed to gather
risk factors and healthcare use statistics
that we have found in preliminary
studies are not otherwise available in
electronic databases or medical records.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated
annualized burden hours associated
61691
with the hospital’s time to participate in
this research. Electronic medical record
data will be collected weekly from 7
participating hospitals, however only
two of these hospitals will use their staff
to perform this data collection. Over the
course of the project electronic medical
record data will be extracted 52 times
and each data extraction will take about
10 hours. Observational data will be
collected weekly from all participating
hospitals, however only 3 hospitals will
use their staff to perform the
observations. The project will require 52
observations per hospital and are
estimated to take about 3 hours to
perform.
Both the social network analysis
questionnaire and the culture
questionnaire will be administered
twice, pretest and posttest, to about 75
personnel at each of the 7 hospitals. The
social network analysis questionnaire
will take about 15 minutes to complete
while the culture questionnaire will
take 30 minutes. The implementation
assessment questionnaire will be
administered quarterly to 3 key
informants at each hospital and will
take about one hour.
The patient healthcare use
questionnaire will be completed by 200
patients sampled from the 7
participating hospitals. Each patient
will respond once which will require
about 15 minutes. The total annualized
burden hours for all the associated data
collections are estimated to be 2,430.
Exhibit 2 shows the estimated
annualized cost burden associated with
the respondents’ time to participate in
this research. The total annual cost
burden is estimated to be $76,118.
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS
Number of hospitals
Form name
Numer of responses per hospital
Hours per response
Total burden
hours
2
3
7
7
7
200
52
52
150
150
12
1
10
3
15/60
30/60
1
15/60
1,040
468
263
525
84
50
Total ..........................................................................................
sroberts on DSKD5P82C1PROD with NOTICES
Electronic Medical Record Data Collection .....................................
Observational Data Collection .........................................................
Social Network Analysis Questionnaire ...........................................
Culture Questionnaire ......................................................................
Implementation Assessment Questionnaire ....................................
Patient Healthcare Use Questionnaire ............................................
226
na
na
2,430
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of hospitals
Form name
Electronic Medical Record Data Collection .....................................
Observational Data Collection .........................................................
Social Network Analysis Questionnaire ...........................................
VerDate Nov<24>2008
17:36 Nov 24, 2009
Jkt 220001
PO 00000
Frm 00037
Fmt 4703
2
3
7
Sfmt 4703
Total burden
hours
Average hourly
wate rate*
1040
468
263
E:\FR\FM\25NON1.SGM
$30.03
$20.98
$38.28
25NON1
Total cost burden
$31,231
9,819
10,068
61692
Federal Register / Vol. 74, No. 226 / Wednesday, November 25, 2009 / Notices
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN—Continued
Number of hospitals
Form name
Total burden
hours
Average hourly
wate rate*
Total cost burden
Culture Questionnaire ......................................................................
Implementation Assessment Questionnaire ....................................
Patient Healthcare Use Questionnaire ............................................
7
7
200
525
84
50
$38.28
$45.33
$21.90
$20,097
$3,808
$1,095
Total ..........................................................................................
226
2,430
na
$76,118
*Based upon the mean of the average wages for Nursing Care Providers ($30.03), Primary Care Physicians ($84.97), Allied Health Providers
($20.98), Administrators, Chief Executives ($76.23) and All Workers ($21.90); National Compensation Survey: Occupational wages in the United
States May 2008, ‘‘U.S. Department of Labor, Bureau of Labor Statistics.’’
Estimated Annual Costs to the Federal
Government
Federal Government over a two-year
period. The total cost of this project is
$1.8 million dollars which includes
$785,000 for project development,
$70,000 for data collection activities,
Exhibit 3 shows the total and
annualized cost of this project to the
$235,000 for data analysis, $125,000 for
publication of the results, $170,000 for
project management and $415,000 for
overhead costs.
EXHIBIT 3—ESTIMATED TOTAL AND ANNUALIZED COST
Cost component
Total cost
Annualized cost
Project Development .......................................................................................................................................
Data Collection Activities .................................................................................................................................
Data Processing and Analysis .........................................................................................................................
Publication of Results ......................................................................................................................................
Project Management ........................................................................................................................................
Overhead .........................................................................................................................................................
$785,000
$70,000
$235,000
$125,000
$170,000
$415,000
$262,000
$35,000
$78,000
$125,000
$57,000
$138,000
Total ..........................................................................................................................................................
$1,800,000
$900,000
sroberts on DSKD5P82C1PROD with NOTICES
Request for Comments
In accordance with the above-cited
Paperwork Reduction Act legislation,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) Whether the
proposed collection of information is
necessary for the proper performance of
AHRQ healthcare research and
healthcare information dissemination
functions, including whether the
information will have practical utility;
(b) the accuracy of AHRQ’s estimate of
burden (including hours and costs) of
the proposed collection(s) of
information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
VerDate Nov<24>2008
17:36 Nov 24, 2009
Jkt 220001
Dated: November 16, 2009.
Carolyn M. Clancy,
Director.
[FR Doc. E9–28211 Filed 11–24–09; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–D–0413]
Guidance for Industry on Residual
Solvents in Drug Products Marketed in
the United States; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
availability of a guidance for industry
entitled ‘‘Residual Solvents in Drug
Products Marketed in the United
States.’’ On July 1, 2008, the United
States Pharmacopeia (USP) published a
new test requirement for the control of
residual solvents, General Chapter
<467> ‘‘Residual Solvents,’’ which
replaced USP General Chapter <467>
‘‘Organic Volatile Impurities.’’ The
change affects all compendial drug
products marketed in the United States.
This guidance reflects FDA’s
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
recommendations on how to comply
with those USP changes.
DATES: Submit written or electronic
comments on agency guidances at any
time.
ADDRESSES: Submit written requests for
single copies of the guidance to the
Division of Drug Information, Center for
Drug Evaluation and Research, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, rm. 2201,
Silver Spring, MD 20993–0002. Send
one self-addressed adhesive label to
assist that office in processing your
requests. Submit written comments on
the guidance to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
electronic comments to https://
www.regulations.gov . See the
SUPPLEMENTARY INFORMATION section for
electronic access to the guidance
document.
FOR FURTHER INFORMATION CONTACT:
Chris Watts, Center for Drug Evaluation
and Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 51, rm. 4142 Silver Spring,
MD 20993–0002, 301–796–1625.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\25NON1.SGM
25NON1
]]>Agencies
[Federal Register Volume 74, Number 226 (Wednesday, November 25, 2009)]
[Notices]
[Pages 61690-61692]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-28211]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the intention of the Agency for
Healthcare Research and Quality (AHRQ) to request that the Office of
Management and Budget (OMB) approve the proposed information collection
project: ``Spreading Techniques to Radically Reduce Antibiotic
Resistant Bacteria (Methicillin Resistant Staphylococcus aureus, or
MRSA).'' In accordance with the Paperwork Reduction Act, 44 U.S.C. 350
1-3520, AHRQ invites the public to comment on this proposed information
collection.
DATES: Comments on this notice must be received by January 25, 2010.
ADDRESSES: Written comments should be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by e-mail at
doris.lefkowitz@AHRQ.hhs.gov.
Copies of the proposed collection plans, data collection
instruments, and specific details on the estimated burden can be
obtained from the AHRQ Reports Clearance Officer.
FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427-1477, or by e-mail at
doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project
Spreading Techniques To Radically Reduce Antibiotic Resistant Bacteria
(Methicillin Resistant Staphylococcus aureus, or MRSA)
Healthcare Acquired Infections (HAIs) caused almost 100,000 deaths
among the 2.1 million people who acquired infections while hospitalized
in 2000, and HAI rates have risen relentlessly since then. Alarmingly,
70% of HATs are due to bacteria that are resistant to commonly used
antibiotics, with Methicillin Resistant Staphylococcus aureus (MRSA)
being the most rapidly growing, and among the most virulent, pathogens.
Resistance is increasing rapidly in all types of hospitals (Huang
2007). Despite evidence that routinely applied, simple interventions do
work, most hospitals have failed to make notable progress in reducing
MRSA infections. Hospitals in some European countries and select U.S.
hospitals, however, have succeeded with impressive results.
Sites that have already achieved dramatic decreases in their MRSA
infection rates have done so by implementing precautions to prevent
transmission, using system redesign approaches. Further, many hospitals
have successfully instituted isolation procedures for patients
suspected to be MRSA carriers. In doing so, these hospitals have
followed the broadly disseminated guidelines for hand hygiene and
contact isolation precautions. This study is a follow up to a recent
study implemented in 6 hospital systems in the Indianapolis
metropolitan area that used a ``MRSA intervention bundle'' composed of
active surveillance screening, contact isolation precautions, and
increased hand hygiene. Preliminary data from that initial study
suggest a 60% decrease in MRSA rates in participating intensive care
units (ICUs) (Doebbeling, B. Redesigning Hospital Care for Quality and
Efficiency Applications of Positive Deviance and Lean in Reducing MRSA.
Presentation at AHRQ Annual Meeting, Rockville, MD, Sept 2009).
This study is designed to further test this intervention bundle in
non-ICU settings in hospitals currently using the intervention bundle
in their ICUs, as well as in additional ICUs in newly recruited
hospital systems. This project will utilize the same guidelines and
precautions that were applied in the original study, and will add an
innovative feature that will use electronic medical record systems to
improve identifying, communicating and tracking MRSA infections among
healthcare systems. More specifically, this study has five aims:
(1) Further test the ``MRSA intervention bundle'' from the original
Indianapolis MRSA study, and test the intervention in additional units
in the 4 original Indianapolis hospital systems and an additional 3
hospital systems beyond Indianapolis;
(2) Identify and monitor healthcare associated community onset
(HACO) MRSA cases and controls who receive care in participating
hospitals and affiliated settings, identify strategies to reduce HACO
MRSA and demonstrate reduction of HACO MRSA;
(3) Assess the relative effectiveness of various antibiotics in
abatement or eradication of MRSA carriage in hospital patients;
(4) Evaluate the effectiveness of the tested implementation
strategies and innovations by applying information technology to enable
consistent collection, sharing, analysis and reporting of data;
(5) Disseminate findings and promote outreach to target audiences
and other stakeholders.
While many secondary data are available for this study, Aims 1 and
2 involve primary data collection. Use of the intervention bundle
requires that opinion leaders and front line workers be equipped with
techniques used in the reorganization of healthcare delivery to improve
health outcomes (Singhal and Greiner, 2007; IHI, 2005). These
techniques will assist in identifying goals, implementing the
interventions to meet local needs and measuring and feeding back
progress on key processes and outcomes to staff and others.
[[Page 61691]]
The study also incorporates an additional informatics surveillance
system to allow participating hospitals to more efficiently
communicate, share and track MRSA infections. This system will save
infection control and clinicians' time--for example, by electronically
identifying patients with a known history of drug-resistant infections
when they first contact a new institution.
This study is being conducted by AHRQ through its contractor,
Indiana University and the Regenstrief Institute, pursuant to AHRQ's
statutory authority to conduct and support research on healthcare and
on systems for the delivery of such care, including activities with
respect to the quality, effectiveness, efficiency, appropriateness and
value of healthcare services and with respect to quality measurement
and improvement. 42 U.S.C. 299a(a)(l) and (2).
Method of Collection
There will be 3 types of data collection to support the study Aims:
Electronic medical record data on MRSA infections and
rates will be collected from an existing and unique healthcare
information exchange (Indiana Network for Patient Care or INPC) in the
Indianapolis area, and the CDC's National Healthcare Safety Network
(Aims 1-5).
Data on hand washing, swabbing, and isolation rates will
be collected by observation (Aims 1, 2, and 4).
Four surveys will be conducted: A brief Social Network
Analysis (SNA), a Cultural Survey, a Patient Healthcare Use survey, and
an Implementation Assessment of key informants (Aims 1, 4, and 5).
The social network analysis questionnaire (SNA) (Wasserman et al.,
1994) will be administered to understand with whom hospital personnel
work, how hospital networks mature over time and how information is
shared. Additionally, cultural beliefs, attitudes, and knowledge will
be captured by surveying staff on intervention units of participating
hospitals using a cultural questionnaire. To compare changes in the
network and cultural beliefs, both the SNA and the cultural
questionnaire will be administered to staff at baseline and again one
year later. These data will be collected from a sample of staff in the
intervention units. Project team leaders will select relevant staff
regularly working and providing patient care or direct patient services
on the unit in a purposive sample. These staff will receive the paper-
based questionnaires during staff meetings and will return them
anonymously. A study ID will serve to determine which staff has
responded and allow linkage of baseline and follow-up surveys.
The implementation assessment will be an interview obtained
quarterly to key informants at each organization to assess the
approaches to implementation of the program (e.g., dose, intensity,
leadership support, teamwork, etc). This assessment will be a short
(10-12) item questionnaire.
Additionally, to better understand the healthcare associated
community acquired aspect of MRSA transmission, 200 patients will be
surveyed to gather risk factors and healthcare use statistics that we
have found in preliminary studies are not otherwise available in
electronic databases or medical records.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated annualized burden hours associated
with the hospital's time to participate in this research. Electronic
medical record data will be collected weekly from 7 participating
hospitals, however only two of these hospitals will use their staff to
perform this data collection. Over the course of the project electronic
medical record data will be extracted 52 times and each data extraction
will take about 10 hours. Observational data will be collected weekly
from all participating hospitals, however only 3 hospitals will use
their staff to perform the observations. The project will require 52
observations per hospital and are estimated to take about 3 hours to
perform.
Both the social network analysis questionnaire and the culture
questionnaire will be administered twice, pretest and posttest, to
about 75 personnel at each of the 7 hospitals. The social network
analysis questionnaire will take about 15 minutes to complete while the
culture questionnaire will take 30 minutes. The implementation
assessment questionnaire will be administered quarterly to 3 key
informants at each hospital and will take about one hour.
The patient healthcare use questionnaire will be completed by 200
patients sampled from the 7 participating hospitals. Each patient will
respond once which will require about 15 minutes. The total annualized
burden hours for all the associated data collections are estimated to
be 2,430. Exhibit 2 shows the estimated annualized cost burden
associated with the respondents' time to participate in this research.
The total annual cost burden is estimated to be $76,118.
Exhibit 1--Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Numer of
Form name Number of responses per Hours per Total burden
hospitals hospital response hours
----------------------------------------------------------------------------------------------------------------
Electronic Medical Record Data 2 52 10 1,040
Collection.............................
Observational Data Collection........... 3 52 3 468
Social Network Analysis Questionnaire... 7 150 15/60 263
Culture Questionnaire................... 7 150 30/60 525
Implementation Assessment Questionnaire. 7 12 1 84
Patient Healthcare Use Questionnaire.... 200 1 15/60 50
-----------------------------------------------------------------------
Total............................... 226 na na 2,430
----------------------------------------------------------------------------------------------------------------
Exhibit 2--Estimated Annualized Cost Burden
----------------------------------------------------------------------------------------------------------------
Number of Total burden Average hourly Total cost
Form name hospitals hours wate rate* burden
----------------------------------------------------------------------------------------------------------------
Electronic Medical Record Data 2 1040 $30.03 $31,231
Collection.............................
Observational Data Collection........... 3 468 $20.98 9,819
Social Network Analysis Questionnaire... 7 263 $38.28 10,068
[[Page 61692]]
Culture Questionnaire................... 7 525 $38.28 $20,097
Implementation Assessment Questionnaire. 7 84 $45.33 $3,808
Patient Healthcare Use Questionnaire.... 200 50 $21.90 $1,095
-----------------------------------------------------------------------
Total............................... 226 2,430 na $76,118
----------------------------------------------------------------------------------------------------------------
*Based upon the mean of the average wages for Nursing Care Providers ($30.03), Primary Care Physicians ($84.97),
Allied Health Providers ($20.98), Administrators, Chief Executives ($76.23) and All Workers ($21.90); National
Compensation Survey: Occupational wages in the United States May 2008, ``U.S. Department of Labor, Bureau of
Labor Statistics.''
Estimated Annual Costs to the Federal Government
Exhibit 3 shows the total and annualized cost of this project to
the Federal Government over a two-year period. The total cost of this
project is $1.8 million dollars which includes $785,000 for project
development, $70,000 for data collection activities, $235,000 for data
analysis, $125,000 for publication of the results, $170,000 for project
management and $415,000 for overhead costs.
Exhibit 3--Estimated Total and Annualized Cost
------------------------------------------------------------------------
Cost component Total cost Annualized cost
------------------------------------------------------------------------
Project Development................. $785,000 $262,000
Data Collection Activities.......... $70,000 $35,000
Data Processing and Analysis........ $235,000 $78,000
Publication of Results.............. $125,000 $125,000
Project Management.................. $170,000 $57,000
Overhead............................ $415,000 $138,000
-----------------------------------
Total........................... $1,800,000 $900,000
------------------------------------------------------------------------
Request for Comments
In accordance with the above-cited Paperwork Reduction Act
legislation, comments on AHRQ's information collection are requested
with regard to any of the following: (a) Whether the proposed
collection of information is necessary for the proper performance of
AHRQ healthcare research and healthcare information dissemination
functions, including whether the information will have practical
utility; (b) the accuracy of AHRQ's estimate of burden (including hours
and costs) of the proposed collection(s) of information; (c) ways to
enhance the quality, utility, and clarity of the information to be
collected; and (d) ways to minimize the burden of the collection of
information upon the respondents, including the use of automated
collection techniques or other forms of information technology.
Comments submitted in response to this notice will be summarized
and included in the Agency's subsequent request for OMB approval of the
proposed information collection. All comments will become a matter of
public record.
Dated: November 16, 2009.
Carolyn M. Clancy,
Director.
[FR Doc. E9-28211 Filed 11-24-09; 8:45 am]
BILLING CODE 4160-90-M
